Baader Bank Aktiengesellschaft’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
Baader Bank Aktiengesellschaft's MTRI Position: Q4 2024 in Review
Baader Bank Aktiengesellschaft sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2024, closing a stake of 113 shares — an estimated $3.84K sold.
Baader Bank Aktiengesellschaft first reported a position in MTRI in Q3 2024 and held it in 1 quarter. The position peaked at $3.84K in Q3 2024. 2 funds tracked by Wall St. Rank hold MTRI as of Q4 2024.
- Baader Bank Aktiengesellschaft reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Baader Bank Aktiengesellschaft sold 113 Mentari Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $3.84K.
- Baader Bank Aktiengesellschaft first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
- Baader Bank Aktiengesellschaft's Mentari Therapeutics, Inc. Common Stock position peaked at $3.84K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.